Data: 08/08/2026
Total encontrado: 3
1/3US=25 / Urologia
Carter HB. The role of prostate-specific antigen velocity in the diagnosis and management of prostate cancer. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 61-70. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

PROSTATICO ESPECIFICO; TRATAMENTO DE CANCER DE PROSTATA; BLINDAGEM; VELOCIDADE DO PSA; PSA TEMPO DE DUPLICACAO; PSA CINETICA


2/3US=25 / Urologia
Karakiewicz PI, Kattan MW. Prostate cancer nomograms and how they measure up to neural networks. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 83-96. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

NOMOGRAMAS DE CANCER DE PROSTATA; NOMOGRAMAS; MODELOS DE PREVISAO; REDES NEURAIS; BLINDAGEM


3/3US=25 / Urologia
Fitzsimons NJ, Bañez LL, Sun LL, Moul JW. Future directions in prostate cancer diagnosis. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 287-312. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

DIAGNOSTICO DE CANCER DE PROSTATA; CANCER DE PROSTATA; BLINDAGEM; PSA; BIOIMAGING BIOMARCADOR